1. Health Economics and Reimbursement, Janssen Inc., Toronto, Canada;
2. EMEA HEMAR, Janssen, High Wycombe, United Kingdom;
3. GHTA-HERO, ICON plc, Abingdon, UK;
4. Global Oncology, Janssen-Cilag GmbH, Neuss, Germany;
5. Global Medical Affairs, Janssen Global Services LLC, Titusville, NJ, USA;
6. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;
7. Medicine, Harvard Medical School, Boston, MA, USA;
8. Haematology, St Vincent’s Hospital, Melbourne, Australia;
9. Hematology Department, Peter MacCallum Cancer Center, Melbourne, Australia;
10. Hematology, University of Melbourne, Melbourne, Australia